Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 11 studies | 31% ± 12% | |
oligodendrocyte | 7 studies | 24% ± 7% | |
basal cell | 5 studies | 29% ± 17% | |
monocyte | 4 studies | 20% ± 6% | |
classical monocyte | 3 studies | 21% ± 4% | |
epithelial cell | 3 studies | 29% ± 9% | |
club cell | 3 studies | 20% ± 3% | |
alveolar macrophage | 3 studies | 37% ± 13% | |
macrophage | 3 studies | 19% ± 2% | |
endothelial cell | 3 studies | 16% ± 1% | |
goblet cell | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1202.03 | 650 / 653 | 98% | 80.72 | 593 / 605 |
bladder | 100% | 1622.90 | 21 / 21 | 97% | 50.96 | 488 / 504 |
lung | 100% | 4561.77 | 578 / 578 | 97% | 53.27 | 1115 / 1155 |
breast | 99% | 1139.25 | 455 / 459 | 95% | 26.25 | 1066 / 1118 |
esophagus | 92% | 2001.23 | 1324 / 1445 | 98% | 54.78 | 180 / 183 |
intestine | 91% | 896.81 | 880 / 966 | 97% | 35.26 | 509 / 527 |
uterus | 96% | 720.35 | 163 / 170 | 91% | 56.60 | 419 / 459 |
stomach | 92% | 690.88 | 329 / 359 | 95% | 25.32 | 271 / 286 |
prostate | 100% | 1663.53 | 244 / 245 | 83% | 14.14 | 419 / 502 |
kidney | 93% | 726.40 | 83 / 89 | 85% | 19.74 | 765 / 901 |
brain | 93% | 973.82 | 2461 / 2642 | 77% | 9.99 | 544 / 705 |
skin | 100% | 3018.18 | 1808 / 1809 | 67% | 13.27 | 318 / 472 |
liver | 94% | 1139.82 | 213 / 226 | 62% | 10.01 | 253 / 406 |
ovary | 58% | 289.21 | 105 / 180 | 85% | 21.55 | 364 / 430 |
adrenal gland | 88% | 643.01 | 228 / 258 | 46% | 6.03 | 105 / 230 |
pancreas | 15% | 78.35 | 49 / 328 | 98% | 36.42 | 174 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.61 | 1 / 1 |
spleen | 99% | 1147.81 | 239 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 1122.00 | 1185 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 74.04 | 44 / 45 |
blood vessel | 96% | 786.13 | 1282 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 20.14 | 26 / 29 |
peripheral blood | 81% | 2855.21 | 753 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 43% | 4.62 | 34 / 80 |
muscle | 37% | 187.15 | 300 / 803 | 0% | 0 | 0 / 0 |
heart | 27% | 132.95 | 229 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902017 | Biological process | regulation of cilium assembly |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0030054 | Cellular component | cell junction |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0070161 | Cellular component | anchoring junction |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0045296 | Molecular function | cadherin binding |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | TBC1D2 |
Protein name | TBC1 domain family member 2A (Armus) (Prostate antigen recognized and identified by SEREX 1) (PARIS-1) |
Synonyms | PP8997 PARIS1 TBC1D2A |
Description | FUNCTION: Acts as a GTPase-activating protein for RAB7A. Signal effector acting as a linker between RAC1 and RAB7A, leading to RAB7A inactivation and subsequent inhibition of cadherin degradation and reduced cell-cell adhesion. . |
Accessions | ENST00000375063.5 [Q9BYX2-6] ENST00000375064.5 [Q9BYX2-3] Q9BYX2 ENST00000375066.6 [Q9BYX2-2] ENST00000465784.7 [Q9BYX2-1] ENST00000342112.9 [Q9BYX2-4] |